Back to 
Nuveen Asset Management, LLC
Nuveen Asset Management, LLC
MCRB
Showing 0 of 19 quarters
Position history for Nuveen Asset Management, LLC's holdings in Seres Therapeutics, Inc.
No. Nuveen Asset Management exited its MCRB (Seres Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 279,471 shares worth $665,141. Nuveen Asset Management first reported MCRB in Q2 2019 and held it in 18 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.